A questionnaire study investigating future pharmacists’ use of, and views on cognitive enhancers



Cognitive Enhancers, Pharmacy Students, Questionnaire


Introduction: This work aimed to ascertain future pharmacists’ use of, and attitudes towards cognitive enhancers (CEs).

Methods: Following ethical approval, all first and final year pharmacy students at Queen's University Belfast (QUB) were invited to complete a pre-piloted, non-identifiable, paper-based questionnaire during a compulsory class. Descriptive statistics were undertaken; non-parametric tests were used for comparisons with significance set at p<0.05 a priori.

Results: The response rates were 89.3% (Level 1) and 89.0% (Level 4) with 48.0% of respondents reporting they were CE users (largely caffeine). Additionally, 42.4% thought using pharmaceutical CEs for improving academic grades breached their Code of Conduct. Level 4 students were more likely to associate over-the-counter (OTC) and prescription-only medicines (POM) CEs with side effects than Level 1 [OTC statement p=0.001 and POM statement p=0.016].

Discussion: CE use among future pharmacists seems quite high; Level 1 students appear more naïve about safety concerns. Educational workshops could further explore ethical issues. 

Author Biography

Lezley-Anne Hanna, Queen's University Belfast

School of Pharmacy, Queen's University Belfast, Senior Lecturer (Education)


Academy of Medical Sciences. (2008). Brain science, addiction and drugs (online). Available at: https:// acmedsci.ac.uk/file-download/34265-524414fc8746 a.pdf. Accessed 22nd June, 2017.

Arnold, L.E. (2000). Methylphenidate vs. amphetamine: comparative review. Journal of Attention Disorders, 3(4), 200-211.

Bennett, T. & Holloway, K. (2017). Motives for illicit prescription drug use among university students: a systematic review and meta-analysis. International Journal of Drug Policy, 44, 12-22.

Bloodworth, A.J., Petróczi, A., Bailey, R., Pearce, G. & McNamee, M.J. (2012). Doping and supplementation: the attitudes of talented young athletes. Scandinavian Journal of Medicine and Science in Sports, 22(2), 293-301.

Bossaer, J.B., Gray, J.A., Miller, S.E., Enck, G., Gaddipati, V.C. & Enck, R.E. (2013). The use and misuse of prescription stimulants as “cognitive enhancers” by students at one academic health sciences center. Academic Medicine, 88(7), 967-971.

British Medical Association. (2015, updated 2017). Employment and career advice. Cognitive enhancing drugs and the workplace (online). Available at: https:// www.bma.org.uk/advice/employment/occupational- health/cognitive-enhancing-drugs. Accessed 22nd June, 2017.

Castaldi, S., Gelatti, U., Orizio, G., Hartung, U., Moreno- Londono, A.M., Nobile, M. & Schulz, P.J. (2012). Use of cognitive enhancement medication among northern Italian university students. Journal of Addiction Medicine, 6(2), 112-117.

Chouakea, J. & Friedman, A. (2012). Herbal medicine in dermatology: does natural = safe? Journal of Drugs in Dermatology, 11(6), 774.

DeSantis, A., Noar, S.M. & Webb, E.M. (2010). Speeding through the frat house: A qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education, 40(2), 157-171.

Dietz, P., Striegel, H., Franke, A.G., Lieb, K., Simon, P. & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44-50.

Dillman D.A. (2008). Internet, mail, and mixed-mode surveys: the tailored design method, 3rd ed. New Jersey: John Wiley & Sons, Inc.

Eickenhorst, P., Vitzthum, K., Klapp, B.F., Groneberg, D. & Mache, S. (2012). Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs. Journal of Psychoactive Drugs, 44(5), 418-427.

Emanuel, R.M., Frellsen, S.L., Kashima, K.J., Sanguino, S.M., Sierles, F.S. & Lazarus, C.J. (2013). Cognitive enhancement drug use among future physicians: Findings from a multi-institutional census of medical students. Journal of General Internal Medicine, 28(8), 1028-1034.

Faraone, S.V., Spencer, T., Aleardi, M., Pagano, C. & Biederman, J. (2004). Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactivity disorder. Journal of Clinical Psychopharmacology, 24(1), 24-29.

Franke, A.G., Bonertz, C., Christmann, M., Huss, M., Fellgiebel, A., Hildt, E. & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60-66.

General Pharmaceutical Council. (2010). Code of Conduct for Pharmacy Students. Available at: https:// www.pharmacyregulation.org/sites/default/ files/Code %20of%20conduct%20for%20phamacy%20students %20s.pdf. Accessed 3rd November, 2016.

General Pharmaceutical Council. (2017). Standards for Pharmacy Professionals, May 2017 (online). Available at: https://www.pharmacy regulation.org/sites/default/files/ standards_for_pharmacy_professionals_may _2017_0.pdf . Accessed 22nd June, 2017.

Habibzadeh, A., Alizadeh, M., Malek, A., Maghbooli, L., Shoja, M.M., Ghabili, K. (2011). Illicit methylphenidate use among Iranian medical students: prevalence and knowledge. Drug Design, Development and Therapy, 5, 71-76.

Hall, H.G., Griffiths, D.L. & McKenna, L.G. (2011). The use of complementary and alternative medicine by pregnant women: a literature review. Midwifery, 27(6), 817-824.

Hall, M., Hanna, L.A., Huey, G. (2013). Use and Views on Social Networking Sites of Pharmacy Students in the United Kingdom. American Journal of Pharmaceutical Education, 77(1), Article 9.

Hall, M., Hanna, L.A., Nixon, R. & Hanna, A. (2015). Alcohol, tobacco, and pharmacy students: Usage and views on professional issues. Currents in Pharmacy Teaching and Learning, 7(4), 476-483.

Hanna, L.A., Barry, J., Donnelly, R., Hughes, F., Jones, D., Laverty, G., Parsons, C. & Ryan, C. (2014). Using debate to teach pharmacy students about ethical issues. American Journal of Pharmaceutical Education, 78(3), Article 57

Harris, C.R., Jenkins, M. & Glaser, D. (2006). Gender differences in risk assessment: why do women take fewer risks than men? Judgment and Decision Making, 1(1), 48.

Jain, R., Chang, C., Koto, M., Geldenhuys, A., Nichol, R. & Joubert, G. (2017). Non-medical use of methylphenidate among medical students of the University of the Free State. South African Journal of Psychiatry, 23(1), 1-5.

Jensen, C., Forlini, C., Partridge, B. & Hall, W. (2016). Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in Psychology, 7. 277.

Kudlow, P.A., Treurnicht Naylor, K., Xie, B. & McIntyre, R.S. (2013). Cognitive enhancement in Canadian medical students. Journal of Psychoactive Drugs, 45(4), 360-365.

Linssen, A.M.W., Sambeth, A., Vuurman, E.F.P.M. & Riedel, W.J. (2014). Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies. International Journal of Neuropsychopharmacology, 17(6), 961-977.

Mache, S., Eickenhorst, P., Vitzthum, K., Klapp, B.F. & Groneberg, D.A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11-12), 262-271.

Maier, L.J., Liechti, M.E., Herzig, F. & Schaub, M.P. (2013). To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PloS One, 8(11), 77967.

Maier, L.J., Liakoni, E., Schildmann, J., Schaub, M.P. & Liechti, M.E. (2015). Swiss university students’ attitudes toward pharmacological cognitive enhancement. PloS One, 10(12), 0144402.

Micoulaud-Franchi, J.A., MacGregor, A. & Fond, G. (2014). A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students. European Review for Medical and Pharmacological Sciences, 18(13), 1875-1878.

Minzenberg, M.J. & Carter, C.S. (2008). Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33(7), 1477-1502.

Nutt, D.J., King, L.A., Saulsbury, W. & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369(9566), 1047-53.

Ott, R. & Biller-Andorno, N. (2014). Neuroenhancement among Swiss students–a comparison of users and non- users. Pharmacopsychiatry, 47(1), 22-28.

Peterson, J.A. & Brommelsiek, M. (2017). Interprofessional education to foster communication and resilience among health professional students. Journal of Interprofessional Education and Practice, 7(1), 1-3.

Ram, S., Hussainy, S., Henning, M., Stewart, K., Jensen, M. & Russell, B. (2017). Attitudes toward cognitive enhancer use among New Zealand tertiary students. Substance Use and Misuse, 1-6, doi: 10.1080/10826084. 2017.1281313 [Epub ahead of print].

Ragan, C.I., Bard, I. & Singh, I. (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588-595.

Rathbone, A. (2017). What is the situation with “smart drugs” use among UK university students? Management, 12, 17.

Roumie, C.L. & Griffin, M.R. (2004). Over-the-counter analgesics in older adults. Drugs and Aging, 21(8), 485-498.

Santacroce, R., Sarchione, F., Corazza, O., Lupi, M., Cinosi, E., Di Giannantonio, M.

& Martinotti, G. (2016). The art of being smart: cognitive enhancement in a population of Italian university students. European Neuropsychopharmacology, 26, S697-S698.

Singh, I., Filipe, A.M., Bard, I., Bergey, M. & Baker, L. (2013). Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians. Current Psychiatry Reports, 15(9), 385.

Singh, I., Bard, I. & Jackson, J. (2014). Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PloS One, 9(10), 105969.

Smith, M.E. & Farah, M.J. (2011). Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, 137(5), 717.

Turner, D.C., Clark, L., Dowson, J., Robbins, T.W. & Sahakian, B.J. (2004). Modafinil improves cognition and response inhibition in adult attention-deficit/ hyperactivity disorder. Biological Psychiatry, 55(10), 1031-1040.

Weyandt, L.L., Oster, D.R., Marraccini, M.E., Gudmundsdottir, B.G., Munro, B.A., Rathkey, E.S. & McCallum, A. (2016). Prescription stimulant medication misuse: Where are we and where do we go from here? Experimental and Clinical Psychopharmacology, 24(5), 400.

Wilens, T.E., Adler, L.A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., Utzinger, L. & Fusillo, S. (2008). Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47(1), 21-31.




How to Cite

Hanna, L.-A., Rainey, J., & Hall, M. (2018). A questionnaire study investigating future pharmacists’ use of, and views on cognitive enhancers. Pharmacy Education, 18, p 76–84. Retrieved from https://pharmacyeducation.fip.org/pharmacyeducation/article/view/567



Research Article